
US imposes 200% tariff on generic drugs; India's industry stunned
The story in brief
The US has imposed a 200% tariff on generic drugs, shocking India's pharmaceutical industry, which supplies 90% of American prescriptions. India relies heavily on China for active pharmaceutical ingredients, and industry leaders warn of challenges in adapting to the new policy. The Pharmaceutical Exports Council of India's chairman called building a generic drug ecosystem in two years unrealistic.